Chelsea Therapeutics, Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 9246
 
  
 
C07D HETEROCYCLIC COMPOUNDS 4158
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8460705 Threo-DOPS controlled release formulationMar 13, 12Jun 11, 13[A61K]
8383681 Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders or attention deficit disordersMay 07, 08Feb 26, 13[A61K]
8158149 Threo-DOPS controlled release formulationJan 29, 07Apr 17, 12[A61K, A01N]
8008285 Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgiaMar 07, 08Aug 30, 11[A61K, A01N]
7951812 Substituted pyrrolo[2,3-d]pyrimidines as antifolatesJan 18, 08May 31, 11[A61K, C07D, A61P]
7829708 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammationSep 08, 05Nov 09, 10[A61K, C07D]
7074831 Compounds, methods for their preparation and use thereofFeb 04, 05Jul 11, 06[A61K]
5912251 Metabolically inert anti-inflammatory and anti-tumor antifolatesJan 17, 98Jun 15, 99[A61K, C07D]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0142,109 ANTIFOLATE COMBINATIONSAbandonedJan 10, 14May 22, 14[A61K]
8658652 Antifolate combinationsExpiredDec 07, 11Feb 25, 14[A61K, A61P]
2013/0253,061 METHOD OF DROXIDOPA SYNTHESISAbandonedMar 08, 13Sep 26, 13[C07C]
8530653 Enzyme inhibiting compoundsExpiredNov 04, 10Sep 10, 13[A01N, C07D]
2013/0197,090 POSTURAL STABILITY AND INCIDENT FUNCTIONS IN PATIENTSAbandonedJan 30, 13Aug 01, 13[A61K]
8461205 Anthranilic acid derivativesExpiredJul 17, 12Jun 11, 13[A61K]
2013/0143,868 DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF MOOD DISORDERS, SLEEP DISORDERS, OR ATTENTION DEFICIT DISORDERSAbandonedJan 25, 13Jun 06, 13[A61K]
2013/0116,286 DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF NEURALLY MEDIATED HYPOTENSIONAbandonedOct 04, 12May 09, 13[A61K]
8263658 Anthranilic acid derivativesExpiredAug 04, 09Sep 11, 12[A61K, C07C]
2012/0010,293 DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF MOOD DISORDERS, SLEEP DISORDERS, OR ATTENTION DEFICIT DISORDERSAbandonedSep 20, 11Jan 12, 12[A61K, A61P]
2011/0237,609 ANTIFOLATE COMPOSITIONSAbandonedMar 24, 11Sep 29, 11[A61K, A61P]
2011/0152,276 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES AS ANTIFOLATESAbandonedFeb 25, 11Jun 23, 11[A61K, A61P]
2011/0124,650 STABLE CRYSTALLINE SALTS OF ANTIFOLATE COMPOUNDSAbandonedJul 07, 10May 26, 11[A61K, C07D, A61P]
2011/0081,338 METABOLICALLY INERT ANTIFOLATES FOR TREATING DISORDERS OF ABNORMAL CELLULAR PROLIFERATION AND INFLAMMATIONAbandonedOct 05, 10Apr 07, 11[A61K, A61P]
2011/0082,149 METABOLICALLY INERT ANTIFOLATES FOR TREATING DISORDERS OF ABNORMAL CELLULAR PROLIFERATION AND INFLAMMATIONAbandonedOct 05, 10Apr 07, 11[A61K, A61P]
2009/0253,719 CRYSTALLINE SALT FORMS OF ANTIFOLATE COMPOUNDS AND METHODS OF MANUFACTURING THEREOFAbandonedApr 07, 09Oct 08, 09[A61K, C07D, A61P]
2009/0253,720 ANTIFOLATE COMPOSITIONSAbandonedApr 07, 09Oct 08, 09[A61K, A61P]
2008/0227,830 DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF NEURALLY MEDIATED HYPOTENSIONAbandonedMar 12, 08Sep 18, 08[A61K]
2008/0015,181 Pharmaceutical Compositions Comprising DroxidopaAbandonedJun 28, 07Jan 17, 08[A61K, A61P]
2007/0010,584 Compositions and methods for orthostatic intoleranceAbandonedSep 01, 04Jan 11, 07[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.